Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$11 Mln
P/E Ratio
--
P/B Ratio
2.14
Industry P/E
--
Debt to Equity
0.25
ROE
-1.14 %
ROCE
-58.4 %
Div. Yield
0 %
Book Value
1.31
EPS
-2.65
CFO
$-12.06 Mln
EBITDA
$-36.45 Mln
Net Profit
$-100.35 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Strata Skin Sciences (SSKN)
| -13.06 | -8.99 | -14.53 | -49.15 | -43.93 | -21.69 | -29.63 |
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
---|---|---|---|---|---|---|---|
Strata Skin Sciences (SSKN)
| -46.82 | -30.39 | -46.26 | -2.00 | -27.88 | -20.00 | 110.52 |
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
15.10 | 10,493.89 | 14.66 | 12.69 | |
71.01 | 9,784.74 | 94.85 | 2.52 | |
152.15 | 8,196.06 | -- | -25.23 | |
277.35 | 10,699.33 | 771.64 | 1.2 |
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South... America. It operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Address: 5 Walnut Grove Drive, Horsham, PA, United States, 19044 Read more
Chief Financial Officer
Mr. Christopher Lesovitz
Chief Financial Officer
Mr. Christopher Lesovitz
Headquarters
Horsham, PA
Website
The total asset value of Strata Skin Sciences Inc (SSKN) stood at $ 36 Mln as on 31-Dec-24
The share price of Strata Skin Sciences Inc (SSKN) is $2.53 (NASDAQ) as of 17-Apr-2025 16:00 EDT. Strata Skin Sciences Inc (SSKN) has given a return of -43.93% in the last 3 years.
Strata Skin Sciences Inc (SSKN) has a market capitalisation of $ 11 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Strata Skin Sciences Inc (SSKN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Strata Skin Sciences Inc (SSKN) and enter the required number of quantities and click on buy to purchase the shares of Strata Skin Sciences Inc (SSKN).
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Address: 5 Walnut Grove Drive, Horsham, PA, United States, 19044
The CEO & director of Mr. Christopher Lesovitz. is Strata Skin Sciences Inc (SSKN), and CFO & Sr. VP is Mr. Christopher Lesovitz.
There is no promoter pledging in Strata Skin Sciences Inc (SSKN).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
1,083
|
|
1,061
|
|
1,022
|
|
889
|
Strata Skin Sciences Inc. (SSKN) | Ratios |
---|---|
Return on equity(%)
|
-114.22
|
Operating margin(%)
|
-24.28
|
Net Margin(%)
|
-30.05
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Strata Skin Sciences Inc (SSKN) was $0 Mln.